Chatham, NJ, United States of America

Michael J Martin

This inventor holds 2 USPTO granted patents. Top assignee: Microdose Therapeutx, Inc.. Active years: 2013-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael J Martin. Retrieved from https://idiyas.com/inventor/michael-j-martin-6wcpkewp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael J Martin: Innovator in Oxybutynin Administration

Introduction

Michael J Martin is a notable inventor based in Chatham, NJ (US). He has made significant contributions to the field of medical treatments, particularly in the administration of oxybutynin. With a total of 2 patents to his name, Martin's work focuses on innovative methods that enhance patient care.

Latest Patents

Martin's latest patents include methods and compositions for the administration of oxybutynin. This innovative approach involves administering oxybutynin directly to a patient's lungs, targeting conditions such as urinary incontinence, respiratory disease, or inflammatory bowel disease (IBD). His work aims to improve the efficacy and delivery of this important medication.

Career Highlights

Michael J Martin is associated with Microdose Therapeutx, Inc., where he continues to develop groundbreaking solutions in the medical field. His expertise and dedication to innovation have positioned him as a key player in the industry.

Collaborations

Martin has collaborated with notable colleagues, including Alan B Watts and Robert Owen Cook. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Michael J Martin's contributions to the field of oxybutynin administration demonstrate his commitment to improving patient outcomes through innovative solutions. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…